Keyphrases
Alternative Splicing
100%
Neuropathology
100%
Acetylcholinesterase
100%
Stress-related
100%
N-terminus
16%
Alzheimer's Disease
16%
Neurodegenerative Diseases
16%
Post-transcriptional Regulation
16%
Enzymatic Activity
16%
C-terminus
16%
Parkinson's Disease
16%
Hydrolytic Enzymes
16%
Therapeutic Agents
16%
RNA Transcripts
16%
Neuroprotection
16%
Pre-mRNA
16%
Promoter Usage
16%
Alternate Promoter
16%
Membrane Association
16%
Multimeric
16%
Myasthenia Gravis
16%
Future Therapeutics
16%
Protein Partners
16%
Association Patterns
16%
Non-hydrolytic
16%
Hydrolysis Properties
16%
Long-term Damage
16%
Neuroscience
Acetylcholinesterase
100%
Alternative Splicing
100%
Amino Terminal Sequence
16%
C-Terminus
16%
Neurodegenerative Disorder
16%
Alzheimer's Disease
16%
Parkinson's Disease
16%
Neuromuscular
16%
Promoter Region
16%
Neuroprotection
16%
Myasthenia gravis
16%
Hydrolase
16%
Enzyme Activity
16%
Precursor mRNA
16%
Post-Transcriptional Regulation
16%
Biochemistry, Genetics and Molecular Biology
Alternative Splicing
100%
Acetylcholinesterase
100%
C-Terminus
16%
N-Terminus
16%
Post-Transcriptional Regulation
16%
Promoter Region
16%
Enzyme Activity
16%
RNA
16%
Hydrolase
16%
Precursor mRNA
16%